Gaudium IVF IPO GMP Today, Date, Price, DRHP & Review 2026

Gaudium IVF IPO GMP, Date, Price, Review, DRHP & Share Price Analysis (2026)

Fertility is a booming business in India. With lifestyle changes and late marriages, IVF clinics are popping up across major cities and even tier-2 towns. Rising stress levels, hormonal imbalances, and changing family planning patterns are driving a silent healthcare revolution.

One of the companies trying to capitalize on this wave is Gaudium IVF & Women Health Limited.

But before you invest, you need clarity.

Is the gaudium ivf ipo a high-growth healthcare stock with scalable potential?Or is it just another regional clinic looking to monetize investor sentiment?

This is your complete, no-nonsense, SEO-optimized deep dive into the Gaudium IVF & Women Health IPO, including GMP trends, DRHP insights, share price valuation, risks, and expert verdict.

Quick Summary 

• IPO Dates: February 18–20, 2026
• Price Band: ₹75–₹79
• Issue Size: 2.08 crore shares
• GMP: ₹12 (approx 15%)
• Listing: BSE & NSE (Mainboard)
• Business: Fertility & IVF clinic chain
• PAT Margin: ~25%
• Risk: Regional concentration & doctor dependency

Gaudium IVF IPO – Key Details (Cheat Sheet)

This is a Mainboard IPO, not an SME IPO. That means better liquidity, institutional participation, and wider investor access.

Gaudium IVF IPO GMP (Grey Market Premium) Today

The gaudium ivf ipo gmp is currently active and reflects cautious yet positive sentiment.

• IPO Price (Upper Band): ₹79
• Latest GMP: ₹12
• Estimated Listing Price: ₹91
• Expected Listing Gain: ~15%

Earlier, the GMP touched ₹15 (~19%), but it slightly cooled to ₹12.

What Does the GMP Indicate?

The Gaudium IVF & Women Health IPO GMP suggests:

• Moderate investor interest
• No speculative frenzy
• Healthcare theme still attractive
• Listing gains possible but not guaranteed

⚠️ Remember: GMP is unofficial and can change rapidly based on subscription numbers and market mood.

About Gaudium IVF & Women Health Limited

The company operates a chain of fertility clinics focused on Assisted Reproductive Technology (ART) services.

Services Offered

• IVF (In Vitro Fertilization)
• IUI (Intrauterine Insemination)
• Egg Freezing
• Fertility Diagnostics
• Women Health Services

By the end of 2025, the company operates:

• 7 Hub centers
• 28 Spoke clinics
• 30+ total locations

Presence in:Delhi, Haryana, Punjab, J&K, Himachal Pradesh, Uttar Pradesh, Bihar, and Mumbai.

Business Model: The Hub & Spoke Strategy

The company follows a “Hub & Spoke” model:

Hubs

Large, fully equipped centers handling:

• Surgeries
• Advanced IVF procedures
• Critical fertility treatments

Spokes

Smaller clinics focusing on:

• Consultations
• Diagnostics
• Basic treatments

Why This Model Works

✔ Lower capital expenditure

✔ Better patient reach

✔ Efficient resource utilization

✔ Centralized quality control

This structure enables rapid expansion without diluting medical standards.

Industry Overview – Why IVF is Growing in India

India’s fertility industry is witnessing strong growth due to:

• Delayed marriages
• Rising infertility rates
• Increased awareness
• Growing disposable income
• Social acceptance of IVF

The Indian IVF market is expected to grow at a strong CAGR over the next decade.

Fertility treatment is largely discretionary but emotionally driven — meaning pricing power remains strong.

Financial Performance Analysis (From Gaudium IVF DRHP)

Let’s look at the numbers disclosed in the gaudium ivf drhp.

Key Observations

1️⃣ Strong Revenue Growth

Revenue grew from ₹44.23 Cr in FY23 to ₹70.72 Cr in FY25.

That’s nearly 60% growth in two years.

2️⃣ High Profit Margins

PAT margins are around 25%.

In healthcare, this is impressive.

IVF treatments carry high pricing power because:

• Patients are emotionally committed
• Insurance coverage is limited
• Limited organized players in many regions

3️⃣ Net Worth Expansion

Net worth more than doubled in three years.

This indicates:

• Profit retention
• Strong balance sheet
• Lower financial stress

Gaudium IVF Share Price Valuation

At ₹79 per share:

• Business shows healthy profitability
• Industry tailwinds exist
• Expansion plans underway

However:

• Regionally concentrated revenue
• Heavy OFS component
• Doctor-centric brand identity

Valuation appears reasonable but execution risk remains.

IPO Structure Breakdown

Fresh Issue

1,13,92,500 shares

Purpose:

• Set up new centers
• Repay borrowings
• Corporate purposes

Offer For Sale (OFS)

94,93,700 shares (~45% of issue)

Promoters are partially exiting.

This indicates:

• Profit booking
• Liquidity event

Though they retain majority control.

Risk Factors You Must Not Ignore

1️⃣ Star Doctor Dependency

The brand revolves heavily around Dr. Manika Khanna.

Healthcare is trust-based.

If:

• Reputation weakens
• She steps away
• Brand perception changes

Patient inflow may drop.

2️⃣ Geographic Concentration Risk

Most revenue comes from Delhi NCR.

Expansion to:

• Mumbai
• Southern India

Will require:

• Marketing investment
• Operational excellence
• Time to build trust

3️⃣ Competitive Landscape

The IVF sector includes:

• Regional clinics
• Multi-city hospital chains
• Organized fertility brands

Pricing pressure may increase.

4️⃣ Regulatory Risks

Healthcare is tightly regulated.

Any changes in:

• ART regulations
• Medical compliance
• Licensing norms

Could impact operations.

Growth Strategy Going Forward

The company plans to:

• Expand into new cities
• Increase spoke network
• Strengthen brand recall
• Enhance technological capabilities

If executed well, scalability exists.

Should You Apply for Gaudium IVF IPO?

For Listing Gains

Depends on:

• Subscription levels
• GMP trend
• Overall market sentiment

Current GMP suggests moderate listing pop possible.

For Long-Term Investors

Consider if you:

• Believe in India’s fertility sector growth
• Are comfortable with execution risk
• Accept regional concentration

Avoid if:

• You prefer diversified healthcare chains
• You dislike promoter OFS heavy IPOs

How to Apply for Gaudium IVF IPO

Investors can apply via:

• Net banking ASBA
• Broker platforms
• Mobile trading apps

For smooth IPO application and tracking, platforms like Firstock  - Option trading app offer:

• Zero brokerage on delivery
• Flat ₹20 per intraday/F&O
• Fast IPO application
• Real-time order tracking

If you're actively applying to IPOs, using a tech-driven platform can simplify the process.

Gaudium IVF IPO vs Healthcare IPOs

Compared to typical healthcare IPOs:

✔ Higher margins

✔ Niche segment

✔ Asset-light expansion

But:

✖ Limited geographic dominance

✖ Doctor-driven brand

Final Verdict

The Gaudium IVF & Women Health IPO represents a profitable, niche healthcare play in a growing fertility market.

It is not yet a national leader, but financially it appears solid.

The positives:

• 25%+ margins
• Growing revenues
• Mainboard listing
• Scalable hub-spoke model

The concerns:

• Regionally concentrated
• Brand dependency
• Promoter selling

If you believe India’s fertility industry will expand significantly over the next decade, the gaudium ivf ipo deserves serious evaluation.

Before applying:

• Read the RHP carefully
• Compare valuation with peers
• Monitor subscription data
• Track GMP trend
• Apply via a reliable trading platform

Long-term wealth is built on informed decisions — not hype.

FAQs

1. When does the gaudium ivf ipo open?

February 18, 2026 to February 20, 2026.

2. What is the gaudium ivf ipo gmp today?

The latest GMP is around ₹12, indicating approximately 15% expected listing gain.

3. What is the gaudium ivf share price band?

₹75 to ₹79 per share.

4. Is Gaudium IVF IPO SME or Mainboard?

It is a Mainboard IPO listing on BSE & NSE.

5. Where can I download the gaudium ivf drhp?

You can access the DRHP on SEBI and stock exchange websites.

6. What will the company do with IPO funds?

• Expansion of centers
• Debt repayment
• General corporate purposes

7. Is the IVF business profitable?

Yes. Based on disclosed numbers, margins are around 25%.

8. What are the main risks?

• Doctor dependency
• Geographic concentration
• Competition
• Regulatory changes

9. Is the OFS portion high?

Yes. Nearly 45% of the issue is Offer For Sale.

10. Should retail investors apply?

Depends on risk appetite and market conditions at the time of subscription.

Disclaimer: Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This article is for educational purposes only and not investment advice.